Inspiremd announces may 16, 2023 as new date for first quarter 2023 results conference call and webcast

- conference call and webcast to be held at 8:30 a.m. edt - tel aviv, israel, may 12, 2023 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) device for the treatment of carotid artery disease and stroke prevention, announced today that it will host its conference call and webcast to review first quarter 2023 financial and operating results on tuesday, may 16th, 2023, before the markets open.
NSPR Ratings Summary
NSPR Quant Ranking